Vaginal cancer is a rare type of cancer that develops in the cells of the vagina. It is most commonly seen in women who are over the age of 60, although younger women may also be diagnosed with it. The most common symptom of vaginal cancer is abnormal bleeding from the vagina, which can range from a small amount of spotting to heavy bleeding. Other symptoms may include a vaginal discharge that is foul-smelling, pain during intercourse, and a general feeling of discomfort in the pelvic area. The cause of vaginal cancer is not well-understood, but certain risk factors have been identified. These include smoking, a history of cervical cancer, exposure to the human papillomavirus (HPV), a weakened immune system, and a history of genital warts. Diagnosis of vaginal cancer typically begins with a physical exam and a Pap smear to look for abnormal cells. Further testing, such as a pelvic exam, lab tests, and imaging tests, may be recommended if cancer is suspected. Treatment for vaginal cancer typically includes surgery to remove the cancerous cells, radiation therapy, and chemotherapy. It is important to note that the treatment plan will depend on the type and stage of the cancer. As with all cancers, early diagnosis is key to successful treatment. Women should be aware of the symptoms of vaginal cancer and seek medical attention if any of them are present. It is also important to get regular Pap smears, as recommended by a doctor, to screen for any abnormal cells in the vagina.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia